Amy Garabedian
General Counsel chez LAVA THERAPEUTICS N.V.
Fortune : 224 772 $ au 31/03/2024
Profil
Amy Garabedian is currently the Secretary & General Counsel at LAVA Therapeutics NV since 2021.
Prior to this, she worked as an Attorney at Ballard Spahr LLP.
From 2015 to 2020, she worked as an Associate General Counsel at Spark Therapeutics, Inc. Ms. Garabedian has a graduate degree from Temple University (Pennsylvania) and Widener University Delaware Law School, and an undergraduate degree from The Pennsylvania State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LAVA THERAPEUTICS NV
0,26% | 28/02/2023 | 67 499 ( 0,26% ) | 224 772 $ | 31/03/2024 |
Postes actifs de Amy Garabedian
| Sociétés | Poste | Début |
|---|---|---|
| LAVA THERAPEUTICS N.V. | General Counsel | 27/07/2021 |
Anciens postes connus de Amy Garabedian
| Sociétés | Poste | Fin |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2020 |
Ballard Spahr LLP
 Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | General Counsel | - |
Formation de Amy Garabedian
| Temple University (Pennsylvania) | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
| Widener University Delaware Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LAVA THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ballard Spahr LLP
Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | Commercial Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
